ascorbic-acid has been researched along with Motor-Neuron-Disease* in 2 studies
2 other study(ies) available for ascorbic-acid and Motor-Neuron-Disease
Article | Year |
---|---|
Pharmacological, morphological and behavioral analysis of motor impairment in experimentally vitamin C deficient guinea pigs.
The scurvy shows an inflammatory disease and gingival bleeding. Nevertheless, in an animal model for guinea pigs, described by Den Hartog Jager in 1985, scurvy was associated with a motor neuron disease with demyelinization of the pyramidal tract, provoking neurogenic atrophy of muscles. Aiming at searching the protective role of vitamin C in nervous system, a pharmacological, morphological and behavioral study was conducted. Three experimental groups were used: A100, animals receiving 100 mg/ vitamin C/ day; A5.0, animals receiving 5.0 mg/vitamin C/ day; and A0, animals without vitamin C. We analyzed the weight gain, muscular diameter and behavioral tests. In all tests examined, we found significant differences between the supplemented groups in comparison with scorbutic group (p<0.05). Thereafter, the animals were killed for histopathology of gastrocnemius muscle, spinal cord and tooth tissues. In addition, a morphometric study of periodontal thickness and alpha-motor neuron cell body diameter were done. The vitamin C-diet free regimen seemed to induce a disruption in spinal cord morphology, involving the lower motor neuron, as confirmed by a significant reduction in neuron perycaria diameter and muscular atrophy, complicated by increased nutritional deficit. Topics: Animals; Antioxidants; Ascorbic Acid; Ascorbic Acid Deficiency; Body Weight; Guinea Pigs; Motor Neuron Disease; Motor Neurons; Muscle, Skeletal; Spinal Cord; Weight Gain | 2003 |
Calcineurin activity is regulated both by redox compounds and by mutant familial amyotrophic lateral sclerosis-superoxide dismutase.
Calcineurin (CN) is a protein phosphatase involved in a wide range of cellular responses to calcium-mobilizing signals, and a role for this enzyme in neuropathology has been postulated. We have investigated the possibility that redox modulation of CN activity is relevant to neuropathological conditions where an imbalance in reactive oxygen species has been described. We have monitored CN activity in cultured human neuroblastoma SH-SY5Y cells and obtained evidence that CN activity is promoted by treatment with ascorbate or dithiothreitol and impaired by oxidative stress. Evidence for the existence of a redox regulation of this enzyme has been also obtained by overexpression of wild-type antioxidant Cu,Zn superoxide dismutase (SOD1) that promotes CN activity and protects it from oxidative inactivation. On the contrary, overexpression of mutant SOD1s associated with familial amyotrophic lateral sclerosis (FALS) impairs CN activity both in transfected human neuroblastoma cell lines and in the motor cortex of brain from FALS-transgenic mice. These data suggest that CN might be a target in the pathogenesis of SOD1-linked FALS. Topics: Animals; Ascorbic Acid; Calcineurin; Calcium; Dithiothreitol; Hippocampus; Humans; Mice; Mice, Transgenic; Motor Cortex; Motor Neuron Disease; Neuroblastoma; Oxidation-Reduction; Oxidative Stress; Recombinant Proteins; Spinal Cord; Superoxide Dismutase; Transfection; Tumor Cells, Cultured | 2000 |